Who is sponsoring NCT00666679?

NCT00666679 is sponsored by Organon and Co.

What drugs are being tested in NCT00666679?

Interventions: Comparator: mometasone, Comparator: montelukast, Comparator: placebo (unspecified).

What is the status of NCT00666679?

NCT00666679 is currently COMPLETED.

Last reviewed 2024-05-07 · How we verify

Randomized, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma

NCT00666679 Phase 2 COMPLETED Results posted

This study assesses inhaled corticosteroid plus montelukast compared with inhaled corticosteroid therapy alone for treatment of patients with chronic asthma.

Details

Lead sponsor	Organon and Co
Phase	Phase 2
Status	COMPLETED
Enrolment	134
Start date	2008-05
Completion	2009-02

Conditions

Asthma

Interventions

Comparator: mometasone
Comparator: montelukast
Comparator: placebo (unspecified)

Primary outcomes

Change From Baseline in FEV1 (Forced Expiratory Volume; Volume of Air That is Exhaled During the First Second of a Forced Exhalation) — Baseline and 2 weeks
To determine the effect of 2 weeks of treatment with inhaled montelukast plus mometasone and mometasone alone on bronchodilation assessed by average change from baseline in FEV1 over the 2 week treatment period; measurements taken at 1 and 2 weeks contributed to the average.